✦ LIBER ✦

Erratum: Malcolm A. Smith, John M. Maris, Richard Gorlick, E. Anders Kolb, Richard Lock, Hernan Carol, Stephen T. Keir, C. Patrick Reynolds, Min H. Kang, Christopher L. Morton, Jianrong Wu, Peter G. Smith, Jie Yu and Peter J. Houghton. Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2012 August; 59(2):246-253

✍ Scribed by Malcolm A. Smith; John M. Maris; Richard Gorlick; E. Anders Kolb; Richard Lock; Hernan Carol; Stephen T. Keir; C. Patrick Reynolds; Min H. Kang; Christopher L. Morton; Jianrong Wu; Peter G. Smith; Jie Yu; Peter J. Houghton

Book ID: 115560683
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 146 KB
Volume: 59
Category: Article
ISSN: 1545-5009
DOI: 10.1002/pbc.24291

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial testing of the investigational N

Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program

✍ Malcolm A. Smith; John M. Maris; Richard Gorlick; E. Anders Kolb; Richard Lock; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

Initial testing of the CENP-E inhibitor

Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program

✍ Richard B. Lock; Hernan Carol; Christopher L. Morton; Stephen T. Keir; C. Patric 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Initial testing (stage 1) of the notch i

Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing program

✍ Carol, Hernan; Maris, John M.; Kang, Min H.; Reynolds, C. Patrick; Kolb, E. Ande 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Initial testing of the MDM2 inhibitor RG

Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program

✍ Hernan Carol; C. Patrick Reynolds; Min H. Kang; Stephen T. Keir; John M. Maris; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 753 KB

Initial testing (Stage 1) of AT13387, an

Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing program

✍ Min H. Kang; C. Patrick Reynolds; Peter J. Houghton; Denise Alexander; Christoph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Initial testing (stage 1) by the pediatr

Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling

✍ E. Anders Kolb; Richard Gorlick; Stephen T. Keir; John M. Maris; Richard Lock; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB